Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with Pre- or post-treatment triple combination cream

Se Yeong Jeong, Jae Bin Shin, Un Cheol Yeo, Won Serk Kim, Il-Hwan Kim

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Background Topical triple combination (TC) treatment is considered the primary approach to melasma. Recently, collimated low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser treatment has attracted attention as an alternative approach. OBJECTIVES To compare the clinical efficacy and adverse effects of low-fluence Q-switched Nd:YAG laser when performed before and after treatment with topical TC using a split-face crossover design. METHODS Thirteen patients with melasma received topical treatment with TC cream or 1,064-nm Q-switched Nd:YAG laser treatment on opposite sides of the face for 8 weeks, and then treatments were reversed for 8 weeks. Responses were evaluated using the Melasma Area and Severity Index scoring system, spectrophotometry measurements, and a subjective self-assessment method. RESULTS After 16 weeks, better results were seen in subjective assessments when laser treatment was used after 8 weeks of topical TC treatment than before usage of TC. There were no significant adverse effects with the laser treatments. CONCLUSIONS Laser treatment after topical TC cream was found to be safer and more effective than the post-treatment use of topical agents. The authors have indicated no significant interest with commercial supporters.

Original languageEnglish
Pages (from-to)909-918
Number of pages10
JournalDermatologic Surgery
Volume36
Issue number6
DOIs
Publication statusPublished - 2010 Jun 1

Fingerprint

Melanosis
Solid-State Lasers
Therapeutics
Lasers
Spectrophotometry
Cross-Over Studies

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with Pre- or post-treatment triple combination cream. / Jeong, Se Yeong; Shin, Jae Bin; Yeo, Un Cheol; Kim, Won Serk; Kim, Il-Hwan.

In: Dermatologic Surgery, Vol. 36, No. 6, 01.06.2010, p. 909-918.

Research output: Contribution to journalArticle

@article{fe8580ee9ad448cfbd201b1856e7c833,
title = "Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with Pre- or post-treatment triple combination cream",
abstract = "Background Topical triple combination (TC) treatment is considered the primary approach to melasma. Recently, collimated low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser treatment has attracted attention as an alternative approach. OBJECTIVES To compare the clinical efficacy and adverse effects of low-fluence Q-switched Nd:YAG laser when performed before and after treatment with topical TC using a split-face crossover design. METHODS Thirteen patients with melasma received topical treatment with TC cream or 1,064-nm Q-switched Nd:YAG laser treatment on opposite sides of the face for 8 weeks, and then treatments were reversed for 8 weeks. Responses were evaluated using the Melasma Area and Severity Index scoring system, spectrophotometry measurements, and a subjective self-assessment method. RESULTS After 16 weeks, better results were seen in subjective assessments when laser treatment was used after 8 weeks of topical TC treatment than before usage of TC. There were no significant adverse effects with the laser treatments. CONCLUSIONS Laser treatment after topical TC cream was found to be safer and more effective than the post-treatment use of topical agents. The authors have indicated no significant interest with commercial supporters.",
author = "Jeong, {Se Yeong} and Shin, {Jae Bin} and Yeo, {Un Cheol} and Kim, {Won Serk} and Il-Hwan Kim",
year = "2010",
month = "6",
day = "1",
doi = "10.1111/j.1524-4725.2010.01523.x",
language = "English",
volume = "36",
pages = "909--918",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with Pre- or post-treatment triple combination cream

AU - Jeong, Se Yeong

AU - Shin, Jae Bin

AU - Yeo, Un Cheol

AU - Kim, Won Serk

AU - Kim, Il-Hwan

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Background Topical triple combination (TC) treatment is considered the primary approach to melasma. Recently, collimated low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser treatment has attracted attention as an alternative approach. OBJECTIVES To compare the clinical efficacy and adverse effects of low-fluence Q-switched Nd:YAG laser when performed before and after treatment with topical TC using a split-face crossover design. METHODS Thirteen patients with melasma received topical treatment with TC cream or 1,064-nm Q-switched Nd:YAG laser treatment on opposite sides of the face for 8 weeks, and then treatments were reversed for 8 weeks. Responses were evaluated using the Melasma Area and Severity Index scoring system, spectrophotometry measurements, and a subjective self-assessment method. RESULTS After 16 weeks, better results were seen in subjective assessments when laser treatment was used after 8 weeks of topical TC treatment than before usage of TC. There were no significant adverse effects with the laser treatments. CONCLUSIONS Laser treatment after topical TC cream was found to be safer and more effective than the post-treatment use of topical agents. The authors have indicated no significant interest with commercial supporters.

AB - Background Topical triple combination (TC) treatment is considered the primary approach to melasma. Recently, collimated low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser treatment has attracted attention as an alternative approach. OBJECTIVES To compare the clinical efficacy and adverse effects of low-fluence Q-switched Nd:YAG laser when performed before and after treatment with topical TC using a split-face crossover design. METHODS Thirteen patients with melasma received topical treatment with TC cream or 1,064-nm Q-switched Nd:YAG laser treatment on opposite sides of the face for 8 weeks, and then treatments were reversed for 8 weeks. Responses were evaluated using the Melasma Area and Severity Index scoring system, spectrophotometry measurements, and a subjective self-assessment method. RESULTS After 16 weeks, better results were seen in subjective assessments when laser treatment was used after 8 weeks of topical TC treatment than before usage of TC. There were no significant adverse effects with the laser treatments. CONCLUSIONS Laser treatment after topical TC cream was found to be safer and more effective than the post-treatment use of topical agents. The authors have indicated no significant interest with commercial supporters.

UR - http://www.scopus.com/inward/record.url?scp=77952961823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952961823&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2010.01523.x

DO - 10.1111/j.1524-4725.2010.01523.x

M3 - Article

C2 - 20384749

AN - SCOPUS:77952961823

VL - 36

SP - 909

EP - 918

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 6

ER -